Skip to content

Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm

Application of Magnetic Activated Cell Sorting (MACS) of Spermatozoa in Artificial Insemination Cycles With Donor Sperm (AID)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03659812
Acronym
MACSIAD
Enrollment
130
Registered
2018-09-06
Start date
2017-11-07
Completion date
2018-04-13
Last updated
2018-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Magnetic activated cell sorting (MACS), Artificial insemination with donor sperm (AID), Spermatozoa, Sperm

Brief summary

The aim of this study is to analyse the efficacy of MACS technique for the selection of spermatozoa and its effects on implantation, pregnancy and miscarriage rate. This study will be performed by two IVI clinics (IVI Sevilla and IVI Madrid) with the purpose of finding new techniques that allow us to better select spermatozoa and improve the results of assisted reproduction techniques.

Interventions

OTHERMACS technique

MACS is a technique that allow us to tag and detect apoptotic spermatozoa. These apoptotic spermatozoa have phosphatidylserine in their membranes, so we add magnetic beads with Annexin V, which binds specifically to phosphatidylserine. The spermatozoa are then tagged and can be retained in a magnetic field, allowing us to collect just the non-apoptotic spermatozoa.

Sponsors

Vida Recoletas Sevilla
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Women who undergo artificial insemination with donor sperm * Signing an informed consent form to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy rateUltrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.The number of pregnancies confirmed by ultrasound divided by the number of artificial insemination cycles. Pregnancy is confirmed by ultrasound examination.
Implantation rateThe beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.The number of positive results of beta human chorionic gonadotropin (hCG) test divided by the number of artificial insemination cycles. Implantation is confirmed through the analysis of beta hCG in blood.
Live birth rateLive births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysisThe number of live births divided by the number of artificial insemination cycles

Secondary

MeasureTime frameDescription
Sperm cells vitalityThis parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).Proportion of live sperm cells before and after applying the MACS technique
Sperm cell concentrationThis parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).Concentration of sperm cells in sperm sample before and after applying the MACS technique
Sperm sample volumeThis parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).The volume of sperm obtained after masturbation
Sperm cell motilityThis parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).Proportion of sperm cells with progressive motility (according to World Health Organisation 2010 criteria) before and after applying the MACS technique
Sperm cell morphologyThis parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).Proportion of sperm cells with normal morphology (according to World Health Organisation 2010 criteria) before and after applying the MACS technique

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026